explore -WSS

explore

author：entertainment 2025-09-06 06:16:26 - browse：789

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout LOUD podcast: ESMO highlights & Roivant's big deal

leisure time

WSS

Colorectal cancer study finds potential in overlooked immune cell

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

What to expect at HLTH 2023, the health care industry conference

Brain injuries and the importance of a second opinion

Physician executives need more than on

Stroke deaths set to near 10 million globally by 2050

leisure time

explore

knowledge

In Memoriam: Notable people who died in 2023

How neuroscience research could help beat back brain cancer

Alkermes shareholders re

Lung cancer screening guidelines updated for cigarette smokers

Malaria cases in Florida and Texas: Here’s what you need to know

All of Us, NIH's precision medicine initiative, gets a big boost

Peter Hotez and the public health issue of online harassment

Why age limits for politicians are a terrible idea

Duchenne breakthrough therapy leaves behind pioneering families

What is microchimerism and how does it affect maternal health?

focus

AI can decode, harness the power of the humane immune system

Travis Kelce and the trap of celebrity vaccine endorsements

What to expect at HLTH 2023, the health care industry conference

VC firm General Catalyst wants to buy a health system

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

focus

focus

leisure time

knowledge